Mitsubishi UFJ Asset Management
VRTX icon

Mitsubishi UFJ Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$234M Buy
524,925
+35,858
+7% +$16M 0.19% 109
2025
Q1
$237M Buy
489,067
+50,976
+12% +$24.7M 0.22% 101
2024
Q4
$178M Buy
438,091
+32,739
+8% +$13.3M 0.17% 115
2024
Q3
$189M Buy
405,352
+33,871
+9% +$15.8M 0.2% 93
2024
Q2
$174M Buy
371,481
+38,339
+12% +$18M 0.21% 93
2024
Q1
$139M Buy
333,142
+57,727
+21% +$24.1M 0.19% 101
2023
Q4
$113M Buy
275,415
+21,332
+8% +$8.76M 0.2% 99
2023
Q3
$88.4M Buy
254,083
+21,257
+9% +$7.39M 0.18% 106
2023
Q2
$81.9M Buy
232,826
+14,709
+7% +$5.18M 0.17% 110
2023
Q1
$68.7M Buy
218,117
+21,230
+11% +$6.69M 0.16% 116
2022
Q4
$56.3M Buy
196,887
+18,898
+11% +$5.41M 0.15% 125
2022
Q3
$51.5M Buy
177,989
+16,591
+10% +$4.8M 0.17% 112
2022
Q2
$45.5M Buy
161,398
+13,151
+9% +$3.71M 0.2% 104
2022
Q1
$38.7M Buy
148,247
+12,079
+9% +$3.15M 0.15% 132
2021
Q4
$30.3M Buy
136,168
+19,729
+17% +$4.39M 0.12% 161
2021
Q3
$21.1M Buy
116,439
+11,348
+11% +$2.06M 0.1% 196
2021
Q2
$21.2M Buy
105,091
+2,794
+3% +$563K 0.12% 180
2021
Q1
$22M Buy
102,297
+11,792
+13% +$2.53M 0.14% 157
2020
Q4
$21.4M Buy
90,505
+8,116
+10% +$1.92M 0.17% 130
2020
Q3
$22.4M Buy
82,389
+17,917
+28% +$4.88M 0.21% 100
2020
Q2
$18.7M Buy
64,472
+12,344
+24% +$3.58M 0.21% 96
2020
Q1
$12.4M Buy
52,128
+1,050
+2% +$250K 0.19% 109
2019
Q4
$11.1M Buy
51,078
+6,523
+15% +$1.42M 0.15% 146
2019
Q3
$7.55M Buy
44,555
+1,825
+4% +$309K 0.12% 176
2019
Q2
$7.84M Buy
42,730
+8,454
+25% +$1.55M 0.13% 155
2019
Q1
$6.31M Buy
34,276
+2,082
+6% +$383K 0.13% 151
2018
Q4
$5.27M Sell
32,194
-2,464
-7% -$403K 0.13% 156
2018
Q3
$6.68M Sell
34,658
-1,072
-3% -$207K 0.14% 148
2018
Q2
$6.07M Buy
35,730
+52
+0.1% +$8.84K 0.13% 156
2018
Q1
$5.82M Sell
35,678
-3,433
-9% -$560K 0.13% 157
2017
Q4
$5.95M Buy
39,111
+1,578
+4% +$240K 0.13% 166
2017
Q3
$5.71M Buy
37,533
+1,108
+3% +$168K 0.13% 163
2017
Q2
$4.69M Sell
36,425
-4,173
-10% -$538K 0.12% 188
2017
Q1
$4.44M Buy
40,598
+1,435
+4% +$157K 0.1% 208
2016
Q4
$2.93M Buy
39,163
+980
+3% +$73.4K 0.07% 290
2016
Q3
$3.33M Buy
38,183
+1,324
+4% +$115K 0.08% 251
2016
Q2
$3.17M Buy
36,859
+1,150
+3% +$98.9K 0.08% 252
2016
Q1
$2.84M Buy
35,709
+3,215
+10% +$256K 0.08% 264
2015
Q4
$4.09M Buy
32,494
+1,927
+6% +$242K 0.12% 167
2015
Q3
$3.18M Buy
30,567
+45
+0.1% +$4.69K 0.1% 199
2015
Q2
$3.77M Sell
30,522
-1,807
-6% -$223K 0.12% 179
2015
Q1
$3.81M Sell
32,329
-1,491
-4% -$176K 0.11% 192
2014
Q4
$4.16M Sell
33,820
-4,225
-11% -$520K 0.13% 177
2014
Q3
$4.27M Sell
38,045
-7,879
-17% -$885K 0.13% 177
2014
Q2
$4.35M Buy
45,924
+249
+0.5% +$23.6K 0.11% 204
2014
Q1
$3.23M Buy
45,675
+2,536
+6% +$179K 0.09% 256
2013
Q4
$3.17M Sell
43,139
-8,162
-16% -$600K 0.09% 242
2013
Q3
$3.89M Buy
51,301
+3,801
+8% +$288K 0.1% 232
2013
Q2
$3.79M Buy
+47,500
New +$3.79M 0.11% 218